contraindications for glp-1 agonists Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs GI Adverse Effects of Glucagon-Like
Description
Increasing evidence has demonstrated that GLP-1 analogues can cross the blood-brain barrier, protect dopaminergic neurons in the substantia nigra, and rescue motor activity and cognitive functions in PD animal models (5961)
As of now, no results from clinical trials with DACRA molecules have been published
Additionally, patients taking multiple medications should be evaluated for potential drug interactions or additive effects, particularly if they are also taking statins, which have well-established myopathic potential
Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis
Effect of Sodium Glucose Cotransporter 2 Inhibitors on Cardiac Function and Cardiovascular Outcome: A Systematic Review
What Its Really About CBO is exploring GLP-1s because these drugs have made AOMs a much more promising weight loss solution than in years past
